Skip to main navigation Skip to search Skip to main content

Clinical Study Protocol M15-942 An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination with Sofosbuvir and Ribavirin in Chronic Hepatitis C (HCV) Infected Subjects Who Have Experienced Virolog

Project: Research

Project Details

StatusFinished
Effective start/end date04/1/17 → 04/1/22

Funding

  • AbbVie Incorporated: $26,854.36